GX Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
Target: Celularity; Closing Date: Jul 16, 2021
IPO Proceeds, $M $287.50M
IPO Date May 21, 2019
CEO Jay R. Bloom; Dean C. Kehler
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24+2
IPO Sector General

Not specified

IPO Geography Global
Target Company Celularity
Deal Announced Jan 8, 2021
Deal Size, $M $1,293.00M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings www.sec.gov
Closing Date Jul 16, 2021
Formerly GXGX CELU CELUW


Sign up for Free Trial

No credit card required

Sign in for more data on GX Acquisition Corp.:

  • 7 directors & officers
  • 26 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
  • 215 shareholders (from 13F filings)